Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 2,233,570 | 1,872,282 | 1,462,043 | 1,106,681 | 448,948 |
| Cost of Goods | 734,840 | 550,379 | 400,966 | 315,981 | 162,201 |
| Gross Profit | 1,498,730 | 1,321,903 | 1,061,077 | 790,700 | 286,747 |
| Operating Expenses | 1,040,060 | 877,924 | 609,074 | 448,922 | 156,936 |
| Operating Income | 459,510 | 444,358 | 452,969 | 342,759 | 130,012 |
| Interest Expense | 67,570 | 14,285 | 11,184 | 8,172 | 2,040 |
| Other Income | -667,250 | -171,405 | -144,814 | -248,814 | 992 |
| Pre-tax Income | -275,310 | 258,668 | 296,971 | 85,773 | 128,964 |
| Income Tax | -10,940 | 98,254 | 129,865 | 77,365 | 49,229 |
| Net Income Continuous | 262,631 | 245,468 | 280,606 | 203,708 | 79,735 |
| Net Income Discontinuous | 0 | -21,080 | 0 | 0 | 0 |
| Net Income | $-264,360 | $139,334 | $167,106 | $8,408 | $79,735 |
| EPS Basic Total Ops | -0.34 | 0.18 | 0.23 | 0.01 | 0.20 |
| EPS Basic Continuous Ops | 0.34 | 0.32 | 0.39 | 0.29 | 0.20 |
| EPS Basic Discontinuous Ops | N/A | -0.03 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.34 | 0.14 | 0.23 | 0.01 | 0.20 |
| EPS Diluted Continuous Ops | 0.34 | 0.31 | 0.39 | 0.29 | 0.20 |
| EPS Diluted Discontinuous Ops | N/A | -0.03 | N/A | N/A | N/A |
| EBITDA(a) | $588,110 | $531,050 | $514,369 | $382,271 | $139,114 |